What is the best diagnostic test for a patient with a long history of taking Ibuprofen (ibuprofen), presenting with melena (black, tarry stools) and a palpable abdominal mass?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The best diagnostic test for a patient with a long history of taking Ibuprofen, presenting with melena and a palpable abdominal mass is upper endoscopy. This recommendation is based on the most recent guidelines, including the 2024 update of the ACR Appropriateness Criteria for nonvariceal upper gastrointestinal bleeding 1. A patient taking ibuprofen long-term who presents with melena (black, tary stools indicating upper GI bleeding) and a palpable mass in the stomach requires urgent evaluation with upper endoscopy.

Key Points to Consider

  • Endoscopy allows direct visualization of the gastric mucosa, identification of the source of bleeding, tissue sampling for histopathology, and potential therapeutic intervention.
  • NSAIDs like ibuprofen are known to cause gastric mucosal damage through inhibition of prostaglandin synthesis, which can lead to ulceration, bleeding, and in some cases, malignancy.
  • The presence of a palpable mass raises concern for a potential gastric tumor, which requires direct visualization and biopsy.
  • While other imaging modalities such as CT, MRI, upper GI series, and ultrasound can provide imaging of gastric abnormalities, they cannot provide tissue diagnosis or immediate therapeutic intervention for active bleeding, making endoscopy the most appropriate initial diagnostic approach in this scenario, as supported by recent guidelines 1.

Clinical Considerations

  • The initial management of nonvariceal UGIB focuses on resuscitation, maintenance of hemodynamic stability, and triage, followed by identification of the source of bleeding and bleeding control 1.
  • Although 80% to 85% of cases of UGIB cease spontaneously, there is a high risk of rebleeding, massive hemorrhage, and death, emphasizing the need for prompt and accurate diagnosis 1.

From the Research

Diagnostic Approach

The patient's presentation with melena and a palpable abdominal mass, along with a long history of taking Ibuprofen, suggests a possible upper gastrointestinal bleed or malignancy. The best diagnostic test for this patient would be:

  • Upper endoscopy, as it allows for direct visualization of the upper gastrointestinal tract and can help identify the cause of bleeding or the presence of a malignancy 2, 3, 4
  • Biopsy and cytology should be performed during endoscopy to increase diagnostic accuracy, especially in cases where a malignancy is suspected 3

Rationale

The use of endoscopy in diagnosing upper gastrointestinal bleeding is well-established, and it has been shown to be effective in identifying the cause of bleeding and guiding management 2, 4. The addition of biopsy and cytology can further increase diagnostic accuracy, especially in cases where a malignancy is suspected 3. Clinical judgment alone is not sufficient to predict the need for endoscopic therapy or to accurately diagnose the cause of upper gastrointestinal hemorrhage 4.

Considerations

It is essential to consider the patient's history of Ibuprofen use, as it may increase the risk of gastrointestinal bleeding. The presence of a palpable abdominal mass also raises the possibility of a malignancy, which would require further evaluation and management. Minimally invasive approaches, such as endoscopic resection, may be considered for the management of benign gastric tumors 5. However, it is crucial to be aware of potential complications, such as hematoma or ulceration, especially in patients with eosinophilic gastroenteritis 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.